Get the Stockscreener App
8.55
4.14%
0.34
After Hours:
8.55
Prothena Corporation Plc stock is traded at $8.55, with a volume of 1.12M.
It is up +4.14% in the last 24 hours and up +21.62% over the past month.
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
See More
Previous Close:
$8.21
Open:
$8.24
24h Volume:
1.12M
Relative Volume:
0.90
Market Cap:
$460.25M
Revenue:
$217.25M
Net Income/Loss:
$-50.92M
P/E Ratio:
-8.55
EPS:
-1
Net Cash Flow:
$-100.85M
1W Performance:
+4.27%
1M Performance:
+21.62%
6M Performance:
-42.81%
1Y Performance:
-58.78%
1-Day Range:
$8.21
$8.585
1-Week Range:
$8.06
$8.585
52-Week Range:
$4.32
$22.71
Prothena Corporation Plc Stock (PRTA) Company Profile
Name
Prothena Corporation Plc
Sector
Industry
Phone
011-353-1-236-2500
Address
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Compare PRTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRTA
Prothena Corporation Plc
|
8.55 | 441.94M | 217.25M | -50.92M | -100.85M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-25 | Downgrade | BofA Securities | Neutral → Underperform |
| May-27-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-27-25 | Downgrade | Jefferies | Buy → Hold |
| May-27-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-20-24 | Initiated | Chardan Capital Markets | Buy |
| Jan-30-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Apr-24-23 | Initiated | SVB Securities | Outperform |
| Jan-27-23 | Initiated | Piper Sandler | Overweight |
| Nov-04-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-28-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-19-21 | Initiated | JMP Securities | Mkt Outperform |
| Jun-18-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jun-08-21 | Reiterated | Oppenheimer | Outperform |
| May-26-21 | Initiated | Citigroup | Buy |
| Feb-26-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-12-21 | Upgrade | Jefferies | Hold → Buy |
| Feb-02-21 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-07-20 | Initiated | H.C. Wainwright | Buy |
| Jul-09-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Nov-19-19 | Upgrade | Evercore ISI | In-line → Outperform |
| May-21-18 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-23-18 | Downgrade | Jefferies | Buy → Hold |
| Apr-05-18 | Reiterated | Barclays | Overweight |
| Nov-20-17 | Downgrade | Wedbush | Outperform → Neutral |
| Sep-29-17 | Reiterated | BTIG Research | Buy |
| Sep-15-17 | Initiated | RBC Capital Mkts | Outperform |
| Aug-17-17 | Initiated | Evercore ISI | Outperform |
| Jul-11-17 | Initiated | Jefferies | Buy |
| Apr-12-17 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-12-17 | Initiated | Piper Jaffray | Overweight |
| Mar-02-17 | Initiated | Instinet | Buy |
| Dec-21-16 | Initiated | SunTrust | Buy |
| Nov-03-16 | Initiated | Deutsche Bank | Buy |
| Aug-04-16 | Reiterated | Barclays | Overweight |
| May-13-16 | Initiated | Barclays | Overweight |
| Feb-19-16 | Reiterated | Wedbush | Outperform |
| Jan-21-16 | Initiated | Credit Suisse | Outperform |
View All
Prothena Corporation Plc Stock (PRTA) Latest News
What high frequency data says about Prothena Corporation plcJuly 2025 Decliners & Community Consensus Picks - Newser
Chart overlay techniques for tracking Prothena Corporation plcSell Signal & Stock Market Timing Techniques - Newser
Will Prothena Corporation plc outperform its industry peers2025 Retail Activity & Low Risk High Win Rate Stock Picks - خودرو بانک
Invesco Ltd. Trims Stock Holdings in Prothena Corporation plc $PRTA - Defense World
What to do if you’re stuck in Prothena Corporation plcJuly 2025 Market Mood & High Accuracy Trade Signal Alerts - Newser
Prothena Corporation plc stock outlook for YEAREarnings Overview Report & Stepwise Entry/Exit Trade Alerts - Newser
Market Rankings: Can Prothena Corporation plc navigate macro headwindsJuly 2025 Big Picture & Free Verified High Yield Trade Plans - خودرو بانک
Relative strength of Prothena Corporation plc in sector analysisBreakout Watch & Verified Technical Trade Signals - Newser
Can swing trading help recover from Prothena Corporation plc lossesTrade Entry Report & Reliable Price Breakout Signals - Newser
Will Prothena Corporation plc price bounce be sustainableJuly 2025 Patterns & Risk Controlled Stock Pick Alerts - Newser
Applying Wyckoff theory to Prothena Corporation plc stockJuly 2025 Outlook & Technical Pattern Based Buy Signals - Newser
Can Prothena Corporation plc lead its sector in growthJuly 2025 Levels & Free Technical Pattern Based Buy Signals - khodrobank.com
Prothena (PRTA) Up 17.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Published on: 2025-09-03 09:24:25 - Newser
Can Prothena Corporation plc benefit from deglobalizationJuly 2025 Macro Moves & Verified Swing Trading Watchlist - خودرو بانک
Best data tools to analyze Prothena Corporation plc stockJuly 2025 Momentum & Community Consensus Picks - Newser
Can Prothena Corporation plc deliver alphaEarnings Growth Report & Proven Capital Preservation Methods - خودرو بانک
Screener Results Flag Prothena Corporation plc as Oversold2025 Historical Comparison & Weekly Hot Stock Watchlists - beatles.ru
How do insiders feel about Prothena Corporation plcJuly 2025 Technicals & Free Weekly Watchlist of Top Performers - خودرو بانک
Is Prothena Corporation plc a turnaround storyJuly 2025 Snapshot & Free Safe Entry Trade Signal Reports - خودرو بانک
How institutional ownership impacts Prothena Corporation plc stockJuly 2025 Chart Watch & Free Reliable Trade Execution Plans - Newser
Is Prothena Corporation plc showing insider buyingBear Alert & Reliable Entry Point Trade Alerts - خودرو بانک
Is Prothena Corporation plc exposed to political riskWeekly Trade Recap & Daily Technical Stock Forecast Reports - خودرو بانک
Tick level data insight on Prothena Corporation plc volatilityJuly 2025 News Drivers & Entry and Exit Point Strategies - Newser
Prothena Corporation plc Chart Enters High Volatility ZoneVolume Spike & Weekly Breakout Opportunity Watchlist - beatles.ru
Can technical indicators confirm Prothena Corporation plc’s reversalIPO Watch & Free Weekly Chart Analysis and Trade Guides - Newser
Multi factor analysis applied to Prothena Corporation plcQuarterly Investment Review & Low Risk Investment Opportunities - Newser
Will a bounce in Prothena Corporation plc offer an exitJuly 2025 Volume & AI Driven Stock Reports - Newser
Live Scanner Shows Breakout on Prothena Corporation plcPortfolio Gains Report & Fast Gain Stock Tips - beatles.ru
Prothena Corporation plc Breaks Losing Streak — Is the Trend Reversing getLinesFromResByArray error: size == 0 - 강소기업뉴스
Using data models to predict Prothena Corporation plc stock movementWeekly Risk Summary & Daily Oversold Stock Bounce Ideas - Newser
Is Prothena Corporation plc still worth holding after the dipSwing Trade & Weekly Top Performers Watchlists - Newser
Ranking Prothena Corporation plc among high performing stocks via toolsWeekly Risk Report & Target Return Focused Picks - Newser
FDA Tightens Safety Guidelines For Biogen Leqembi Alzheimer's Therapy - Benzinga
Prothena Corporation Plc Stock (PRTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):